[
    [
        {
            "time": "2023-10-18",
            "original_text": "传疫苗业务试点外包，销售团队签“业绩对赌”，“宇宙厂”辉瑞开启大调整",
            "features": {
                "keywords": [
                    "疫苗",
                    "业务外包",
                    "销售团队",
                    "业绩对赌",
                    "辉瑞",
                    "大调整"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "传疫苗业务试点外包，销售团队签“业绩对赌”，“宇宙厂”辉瑞开启大调整",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]